Refractory Acute Leukemia of Ambiguous Lineage
4 clinical trials · Condition
◉ Watch Refractory Acute Leukemia of Ambiguous Lineage
| Record | Firm | Date |
|---|---|---|
| Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia (NCT04898894) | St. Jude Children's Research Hospital | 2021-11-15 |
| CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia (NCT04375631) | Fred Hutchinson Cancer Center | 2020-12-03 |
| High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia (NCT02551718) | University of Washington | 2015-09-11 |
Track Refractory Acute Leukemia of Ambiguous Lineage automatically
Every clearance here is in the API, with alerts when new ones post.